The National Study of Sero-Epidemiology ENE-COVID concludes that 5% of the Spanish population has antibodies. This percentage has hardly changed in the three waves of which it consists: in the first it was estimated at 5% and in the second and third it has been 5.2%. An overall seroconversion rate (people who did not have antibodies in the first wave and who developed them throughout the study by having contact with the virus) of 0.9% has been observed between round 1 and round 2, a somewhat lower percentage (0.7%) between round 2 and round 3. These figures reflect the low occurrence of new infections after confinement.
The Carlos III Health Institute (ISCIII) has created a scientific analysis group on the coronavirus SARS-CoV-2 and COVID-19 disease. The group was born with the intention of providing a reliable source of information based on the available scientific evidence, and of responding to the main doubts and debates about the virus and the disease. This is also intended to generate another tool in the global fight against possible misinformation and false messages about the coronavirus. (More information)
- 02/07/2020: Anticuerpos neutralizantes frente a SARS-CoV-2 (conprueba.es)
- 02/07/2020: Evolución del coronavirus SARS-CoV-2 (conprueba.es)
- 16/06/2020: Problemas de coagulación y trombos en pacientes con COVID-19 (conprueba.es)
- 16/06/2020: Tipología de estudios clínicos (conprueba.es)
- 01/06/2020: Detección de SARS-CoV-2 en aguas residuales como herramienta de vigilancia y alerta rápida (conprueba.es)
- 01/06/2020: Factores de riesgo en la enfermedad por SARS-COV-2 (COVID-19) (conprueba.es)
- 27/05/2020: Desarrollo de vacunas frente al SARS-COV-2 (conprueba.es)
- 19/05/2020: Difusión y comunicación de la ciencia (conprueba.es)
- 08/05/2020: La respuesta inmunitaria frente al coronavirus SARS-COV-2 (conprueba.es)
- 08/05/2020: Manifestaciones clínicas de la enfermedad COVID-19 (conprueba.es)
- 21/04/2020: Necesidad de encontrar fármacos frente a la enfermedad COVID-19 (conprueba.es)
- 20/04/2020: Secuenciación genética: ¿Qué es y para qué sirve? (conprueba.es)
-
21/10/2020: Guide for ventilation of CSIC classrooms (updated 16/12/2020)
PDF (ES) (1 MB) -
01/04/2020: Diagnostic techniques and systems for COVID-19: classification, characteristics, advantages and limitations
PDF (ES) (512 KB) -
01/04/2020: Diagnostic techniques and systems for COVID-19: classification, characteristics, advantages and limitations. Version disclosure
PDF (ES) (243 KB)
The Multidisciplinary Working Group (GTM) advises and supports the Government in scientific matters related to COVID-19 and its future consequences. It also produces reports and proposes measures to improve the response to similar crises.
Members of the Group:
- Beatriz González López-Valcárcel, Professor of Quantitative Methods in Economics at the University of Las Palmas de Gran Canaria and researcher in Health Economics, specifically in Human Resources for Health, Health Technologies or Pharmaceuticals. He has carried out consultancies in several countries.
- José M. Ordovás, PhD in Biochemistry from the University of Zaragoza, professor and researcher of Nutrition at the USDA-Human Nutrition Research Center on Aging of the University of Tufts in Boston, where he is also the director of the Laboratory of Nutrition and Genomics. researcher at the Madrid Institute of Advanced Studies (IMDEA) Food. He acts as president of the group.
- Marco Inzitari, specialist in geriatric medicine. He is the director of Intermediate Care, Research and Teaching at the Parc Sanitari Pere Virgili, and associate professor at the Autonomous University of Barcelona. He is also a researcher at the Vall d’Hebron Research Institute.
- José Javier Ramasco, PhD in Physics from the University of Cantabria and senior scientist at the Higher Council for Scientific Research (CSIC). He develops his work at the Institute of Interdisciplinary Physics and Complex Systems. He is the author of more than 86 scientific publications cited more than 7,500 times.
- Itziar de Lecuona, PhD in Law from the University of Barcelona, professor in the Department of Medicine and deputy director of the Observatory of Bioethics and Law (OBD). UNESCO Chair in Bioethics at the University of Barcelona.
- Alfonso Valencia, PhD in Molecular Biology from the Autonomous University of Madrid, is director of the Department of Life Sciences of the Barcelona Supercomputing Center-National Center for Supercomputing. He is also director of the National Institute of Bioinformatics (INB-ISCIII) and coordinator of the Spanish node of the European infrastructure ELIXIR. ICREA Research Professor.
- Diego Puga, PhD in Economics from the London School of Economics, Professor of Economics at the Centre for Monetary and Financial Studies in Madrid. His research includes urban economics, economic geography and international trade.
- Laura M. Lechuga, research professor at the CSIC, director of the Group of Nanobiosensors and Bioanalytical Applications at the Catalan Institute of Nanoscience and Nanotechnology.
- Mariano Esteban, Professor Ad Honorem of the National Center of Biotechnology of the CSIC and head of the Vaccines group.
- Jose Molero, Professor of Applied Economics at the Complutense University of Madrid and Professor of Industrial Economics and Economics of Innovation.
- Pedro Jordano, Research Professor at the CSIC in the Biological Station of Doñana (Seville). Expert in the study of biological diversity (biodiversity) from ecological and evolutionary perspectives. National Research Award 2018.
- Alfonso Gordaliza, PhD in Mathematics from the University of Valladolid, Professor of Statistics and Operational Research from the University of Valladolid and President of the Spanish Mathematics Committee. He is an expert in Robust Statistics.
- Rocío García-Retamero, professor at the Department of Experimental Psychology at the University of Granada. She is an expert in risk perception and health psychology and medical decision making.
- Agustín Portela, PhD in Biological Sciences from the Autonomous University of Madrid, was a researcher in Basic Virology. He is head of area at the Spanish Agency of Medicines and Health Products where he is responsible for the clinical evaluation of human vaccines and the laboratory of Biological Products.
- Ramón López de Mántaras, research professor at the CSIC and founder and former director of the Artificial Intelligence Research Institute (IIIA). He is a pioneer of AI in Spain, with almost 300 research articles. National Research Award 2018.
- Francisco Sánchez Madrid, PhD in Biochemistry from the Autonomous University of Madrid in 1980. He completed his training in Immunology at Harvard Medical School, Boston, United States. He has been Professor of Immunology at the Department of Medicine of the Autonomous University of Madrid since 1990, and Head of Immunology Service at the Hospital Universitario de la Princesa since 2009. Scientific director of the Princess Health Research Institute.
-
24/03/2022: GMT report on persistent COVID
PDF (ES) (542 KB) -
05/21/2020: Analysis of the report of the German Academy of Sciences
PDF (ES) (236 KB) -
16/06/2020: GTM Report on Changes in the Science, Technology and Innovation System (SCTI)
PDF (ES) (220 KB) -
03/06/2020: Positioning the GTM on a possible immunological passport (updated 08/06/2020)
PDF (ES) (157 KB)
-
06/08/2020: Report on atmosphere and COVID-19
PDF (ES) (423 KB) -
01/07/2020: GTM report on the impact of COVID-19 on older people, with special emphasis on those living in residences
PDF (ES) (674 KB) -
11/08/2020: Report on the validity and interpretation of diagnostic tests for SARS-CoV-2
PDF (ES) (596 KB) -
15/01/2021: Update of the GTM report on COVID-19 diagnostic tests
PDF (ES) (768 KB) -
15/01/2021: Annexes analytical technical tables COVID-19
PDF (ES) (1 MB) -
11/08/2020: Notes for a new economic strategy
PDF (ES) (317 KB) -
11/08/2020: Report on paediatric immunity and the reopening of the school system in the time of COVID-19
PDF (ES) (348 KB) -
11/08/2020: Report on COVID-19 in indoor spaces, in particular restaurants
PDF (ES) (271 KB) -
18/11/2020: GTM1 report on nutrition practice and research in times of COVID-19
PDF (ES) (762 KB) -
25/11/2020: Report of the GTM on the proposal of an expert selection for a Technological and Industrial policy
PDF (ES) (997 KB) -
30/11/2020: GTM Report on “Vaccines against SARS-CoV-2 causing COVID-19: Concepts and developments”
PDF (ES) (619 KB) -
11/12/2020: GTM1 report on "Data and information on the COVID-19 epidemic and proposals for the digital evolution of the health system"
PDF (ES) (1 MB) -
12/23/2020: GTM1 Report on "Protective Immunity and Reinfection in COVID-19"
PDF (ES) (255 KB) -
29/01/2021: Positioning the GTM on “Lessons from the SARS-CoV-2 pandemic in biomedical research: A reflection of the actions carried out to build a new approach for the future”
PDF (ES) (688 KB) -
05/03/2021: Report of the GTM1 on “Recruitment of scientific personnel in the Public Research System”
PDF (ES) (282 KB) -
24/03/2021: GTM Report on SARS-CoV-2 Variants and Implications for Global COVID-19 Vaccination Programs
PDF (ES) (1 MB) -
05/04/2021: GTM Report on Inequalities and COVID-19
PDF (ES) (1 MB) -
04/08/2021: Report of the GTM1: Understanding and combating disinformation about science and health
PDF (ES) (1 MB) -
21/04/2021: GTM1 Report on “Possibility of using sample grouping for antigen testing”
PDF (ES) (1 MB) -
03/05/2021: GTM1’s report on how many trackers are needed?
PDF (ES) (1 MB) -
05/20/2021: GTM Report on Pandemic Fatigue
PDF (ES) (1 MB) -
05/21/2021: GTM report on current therapy against SARS-CoV-2/COVID-19
PDF (ES) (1 MB) -
02/06/2021: GTM report: autonomous air cleaning equipment and sensors for controlling the transmission of SARS-CoV-2 by aerosols
PDF (ES) (2 MB) -
06/18/2021: GTM report on innovative business activities other than R[amp]D: notes for a new innovation policy
PDF (ES) (792 KB) -
21/07/2021: GTM report on “Environmental aspects of COVID-19. Part I”
PDF (ES) (1 MB) -
21/07/2021: GTM report on “Environmental aspects of COVID-19. Part II”
PDF (ES) (1 MB)